Abstract
Voriconazole, amphotericin B (AmB) formulations, and isavuconazole are all included in guideline recommendations for treatment of patients with invasive aspergillosis (IA) but the relative efficacy of isavuconazole versus AmB formulations has not been directly compared. We aimed to estimate the relative efficacy of isavuconazole compared with AmB deoxycholate (AmB-D), liposomal AmB (L-AmB), and voriconazole for the treatment of patients with proven/probable IA. Nine literature databases were screened for randomized controlled trials comparing treatments with any of voriconazole, AmB-D, L-AmB and isavuconazole for treatment of proven/probable IA. Articles meeting the criteria were included in a meta-analysis to determine the efficacy of AmB-D, L-AmB and voriconazole relative to isavuconazole based on all-cause mortality (ACM) and overall response using a fixed-effects model. Four articles were identified that compared L-AmB with AmB-D (Study 1), standard-dose L-AmB (3-5 mg/kg/day) with high-dose L-AmB (10 mg/kg/day; Study 2), voriconazole with AmB-D (Study 3), and isavuconazole with voriconazole (Study 4). In the network meta-analysis, isavuconazole was statistically superior to AmB-D on both ACM (odds ratio [95% credible interv...Continue Reading
References
Oct 29, 1998·British Journal of Haematology·A C LeendersS de Marie
Dec 4, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·S AsciogluUNKNOWN Mycoses Study Group of the National Institute of Allergy and Infectious Diseases
Aug 9, 2002·The New England Journal of Medicine·Raoul HerbrechtUNKNOWN Invasive Fungal Infections Group of the European Organisation for Research and Treatment of Cancer and the Global Aspergillu
Sep 5, 2002·Statistics in Medicine·Thomas Lumley
Sep 28, 2004·Statistics in Medicine·G Lu, A E Ades
Oct 19, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Thomas F PattersonUNKNOWN Pfizer Global Aspergillus Study Group
Apr 20, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Oliver A CornelyUNKNOWN AmBiLoad Trial Study Group
Oct 11, 2007·Statistical Methods in Medical Research·Georgia SalantiJohn P A Ioannidis
May 9, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Ben De PauwUNKNOWN National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
Jul 22, 2009·PLoS Medicine·David MoherUNKNOWN PRISMA Group
Aug 28, 2009·Australian Dental Journal·UNKNOWN Australian Research Centre for Population Oral Health, The University of Adelaide, South Australia
Nov 3, 2010·Mycoses·Oliver A CornelyJ Peter Donnelly
Jan 1, 2010·Drug, Healthcare and Patient Safety·Dionissios NeofytosAnna-Pelagia Magiorakos
Oct 30, 2012·Medical Decision Making : an International Journal of the Society for Medical Decision Making·Sofia DiasNicky J Welton
Oct 5, 2013·Journal of Clinical Epidemiology·Andrew W Lee
Aug 12, 2014·International Journal of Antimicrobial Agents·Michael J Dolton, Andrew J McLachlan
Nov 22, 2014·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Raoul HerbrechtPeter G Pappas
Sep 24, 2015·Seminars in Respiratory and Critical Care Medicine·Kevin S Gregg, Carol A Kauffman
Dec 20, 2015·Lancet·Johan A MaertensAndrew J Ullmann
Jan 29, 2016·Drugs·Neil R H StoneWilliam Hope
Mar 24, 2016·Antimicrobial Agents and Chemotherapy·David AndesJames Spalding
Jun 9, 2016·Clinical Pharmacology in Drug Development·Robert TownsendAmit Desai
Jul 2, 2016·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Thomas F PattersonJohn E Bennett
Dec 25, 2016·Haematologica·Frederic TissotRaoul Herbrecht
Mar 17, 2018·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·A J UllmannO A Cornely